ARCHIVES

ODAC Recommends Iressa Approval As Third-Line Lung Cancer Treatment

This article is from The Cancer Letter archive.

Vol. 28 No. 35 | September 27, 2002

Download PDF Visit The Full Archive

Related Articles

Panel Clear On Breast Conservation, Not On Adjuvant Therapy For Node

June 29, 1990

NCI Faces Major Cuts On Gramm-Rudman Sequestration; Grants, Centers, Trials Slashed

November 3, 1989

Kennedy Bills Would Authorize Senior Scientist Service, New Foundation, Construction Grants

July 28, 1989

Preoperative Drug Combo Benefits HER-2 Breast Cancer

April 29, 2005

Alan Rabson Named NCI Deputy Director

August 11, 1995

Ruffin Sworn In As Director, NIH Minority Health Center.

January 12, 2001